![William Hodder](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
William Hodder
Directeur Général chez NFlection Therapeutics, Inc.
Postes actifs de William Hodder
Sociétés | Poste | Début | Fin |
---|---|---|---|
NFlection Therapeutics, Inc.
![]() NFlection Therapeutics, Inc. BiotechnologyHealth Technology NFlection Therapeutics, Inc. operates as a biotechnology company. It focuses on the development of therapies for Neurofibromatosis. The company was founded by Mark de Souza and Michael Wootton in 2014 and is headquartered in Wayne, PA. | Directeur/Membre du Conseil | 18/10/2021 | - |
Directeur Général | 18/10/2021 | - | |
President | 18/10/2021 | - |
Historique de carrière de William Hodder
Anciens postes connus de William Hodder
Sociétés | Poste | Début | Fin |
---|---|---|---|
Promedior, Inc.
![]() Promedior, Inc. Medical SpecialtiesHealth Technology Promedior, Inc. is a clinical-stage immunotherapy company, which engages in the development of targeted therapeutics to treat fibrotic diseases. Its proprietary therapeutic platform is based upon Pentraxin-2, an endogenous human protein that plays an important role in regulating the response to fibrosis. The company was founded by Gomer H. Richard, Lawrence M. Kauvar, and Darrell Pilling in April 2006 and is headquartered in Lexington, MA. | Corporate Officer/Principal | 01/12/2013 | 01/07/2014 |
Trenovus, Inc. | Directeur Général | 01/01/2010 | 01/01/2012 |
Fondateur | 01/01/2010 | 01/01/2012 | |
ARADIGM CORPORATION | Sales & Marketing | 01/01/1997 | 01/01/2001 |
Vapogenix, Inc.
![]() Vapogenix, Inc. Medical/Nursing ServicesHealth Services Vapogenix, Inc. operates as a clinical stage company which develops a new class of non-narcotic analgesics for localized pain. Its products are formulated volatile anesthetics; currently unformulated volatile anesthetics are used only as general anesthetics, by inhalation. The company was founded by Allen W. Burton, Phillip C. Phan and Danguole Spakevicius Altman in November 2007 and is headquartered in Houston, TX. | Directeur/Membre du Conseil | - | - |
Directeur Général | - | - | |
President | - | - | |
PROTAGONIST THERAPEUTICS, INC. | Corporate Officer/Principal | 18/12/2014 | - |
FIBROGEN, INC. | Corporate Officer/Principal | - | - |
Formation de William Hodder
Oakland University (Michigan) | Undergraduate Degree |
The University of Chicago Booth School of Business | Masters Business Admin |
Statistiques
Internationale
Etats-Unis | 10 |
Opérationnelle
Corporate Officer/Principal | 3 |
Chief Executive Officer | 3 |
Director/Board Member | 2 |
Sectorielle
Health Technology | 6 |
Consumer Services | 3 |
Health Services | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
Sociétés cotées | 2 |
---|---|
FIBROGEN, INC. | Health Technology |
PROTAGONIST THERAPEUTICS, INC. | Health Technology |
Entreprise privées | 5 |
---|---|
Aradigm Corp.
![]() Aradigm Corp. Pharmaceuticals: MajorHealth Technology Aradigm Corp. was a pharmaceutical company, which was focused on the development and commercialization of drugs delivered by inhalation for the prevention and treatment of severe respiratory diseases by pulmonologists. The company was founded in 1991 and was headquartered in Hayward, CA. | Health Technology |
Vapogenix, Inc.
![]() Vapogenix, Inc. Medical/Nursing ServicesHealth Services Vapogenix, Inc. operates as a clinical stage company which develops a new class of non-narcotic analgesics for localized pain. Its products are formulated volatile anesthetics; currently unformulated volatile anesthetics are used only as general anesthetics, by inhalation. The company was founded by Allen W. Burton, Phillip C. Phan and Danguole Spakevicius Altman in November 2007 and is headquartered in Houston, TX. | Health Services |
Promedior, Inc.
![]() Promedior, Inc. Medical SpecialtiesHealth Technology Promedior, Inc. is a clinical-stage immunotherapy company, which engages in the development of targeted therapeutics to treat fibrotic diseases. Its proprietary therapeutic platform is based upon Pentraxin-2, an endogenous human protein that plays an important role in regulating the response to fibrosis. The company was founded by Gomer H. Richard, Lawrence M. Kauvar, and Darrell Pilling in April 2006 and is headquartered in Lexington, MA. | Health Technology |
Trenovus, Inc. | |
NFlection Therapeutics, Inc.
![]() NFlection Therapeutics, Inc. BiotechnologyHealth Technology NFlection Therapeutics, Inc. operates as a biotechnology company. It focuses on the development of therapies for Neurofibromatosis. The company was founded by Mark de Souza and Michael Wootton in 2014 and is headquartered in Wayne, PA. | Health Technology |
- Bourse
- Insiders
- William Hodder
- Expérience